Clinical Applications of Immuno-PET in Lymphoma: A Systematic …
WEBJul 18, 2022 · Immuno-positron emission tomography (iPET) is a whole-body molecular imaging technique that combines the high sensitivity, resolution, and quantitative ability of PET imaging to the specific binding properties of monoclonal antibodies (mAb) [ 1 ].
Clinical Applications of Immuno-PET in Lymphoma: A Systematic …
WEBJul 18, 2022 · Objective: Immuno-positron emission tomography (iPET) combines the sensitivity of the PET imaging technique and the targeting specificity of radio-labelled monoclonal antibodies (mAb). Its first clinical applications in humans were described in the late 1990s, and several pathologies have benefitted …
Clinical Applications of Immuno-PET in Lymphoma: A Systematic …
WEBJul 18, 2022 · Objective: Immuno-positron emission tomography (iPET) combines the sensitivity of the PET imaging technique and the targeting specificity of radio-labelled monoclonal antibodies (mAb). Its first clinical applications in humans were described in the late 1990s, and several pathologies have benefitted …
FDG-PET/CT in Lymphoma: Where Do We Go Now? - PMC
WEBOct 18, 2021 · The concept of interim PET (iPET) emerged in the last ten years and allows for analyzing a continuous metabolic process during treatment [14,15]. When performed after one or two cycles, iPET allows for evaluating the response of cells with the highest level of proliferation and identifying early responding chemosensitive patients without the ...
ImmunoPET: Antibody-Based PET Imaging in Solid Tumors
WEBJun 28, 2022 · ImmunoPET is molecular imaging used for (1) the evaluation of biodistribution of Abs or their fragments in normal and malignant tissues, (2) the non-invasive detection of expression of target molecules and their heterogeneity in whole-body, and 3) prediction of response to targeted therapies ( 15 ).
Interim PET-CT–guided therapy in elderly patients with ... - Springer
WEBMay 18, 2019 · Our findings show that iPET is highly predictive of outcome in elderly HL patients and provide evidence that iPET-guided therapy in this patient population may be key to achieving superior treatment outcome.
Clinical Applications of Immuno-PET in Lymphoma: A Systematic …
WEBJul 18, 2022 · Objective: Immuno-positron emission tomography (iPET) combines the sensitivity of the PET imaging technique and the targeting specificity of radio-labelled monoclonal...
Interobserver variability in interim PET assessment in Hodgkin
WEBMar 28, 2023 · Interim PET (iPET) assessment is important for response adaptation in Hodgkin lymphoma (HL). The current standard for iPET assessment is the Deauville score (DS). The aim of our study was to evaluate the causes of interobserver variability in assigning the DS for iPET in HL patients and to make suggestions for …
Interim FDG-PET/CT for Response Assessment of Lymphoma
WEBAbstract. The clinical use and prognostic value of interim FDG-PET/CT (iPET/CT), which is performed after treatment initiation but prior to its completion, varies by lymphoma subtype.
Evaluation of Chelator-to-Antibody Ratio on Development of 89Zr-iPET …
WEBDec 5, 2023 · The success of ICI mAbs in cancer treatment has widened the application of immuno-positron emission tomography (iPET) in the field of nuclear medicine. iPET combines the high binding specificity of antibodies with the high sensitivity of positron emission tomography, enabling a noninvasive, whole-body, and dynamic evaluation of PD-L1 expression ...